Literature DB >> 9370945

The association between tumour progression and vascularity in the oral mucosa.

S Pazouki1, D M Chisholm, M M Adi, G Carmichael, M Farquharson, G R Ogden, S L Schor, A M Schor.   

Abstract

Tumourigenesis in experimental models is associated with the formation of new blood vessels (angiogenesis). Recent studies have suggested that tumour angiogenic activity may be inferred in histological sections by measuring the density of the vasculature. The purpose of this study was to determine whether the transition from normal to dysplastic and neoplastic tissue in the oral mucosa is accompanied by quantitative or qualitative changes in the vascularity of the tissue, and how the estimate of vascularity is influenced by the vessel marker and method of assessment. A total of 100 specimens of normal oral mucosa, dysplastic lesions, and squamous cell carcinomas were examined. Sections were immunostained with the pan-endothelial antibodies to von Willebrand Factor (vWF) and CD31, or with an antibody to the alpha v beta 3 integrin, previously reported to be a marker of angiogenic vessels. Vascularity was quantitated by two different methods: highest microvascular density (h-MVD) and microvascular volume, as determined by point counting (MVV). The results showed that vascularity, measured by the MVV method using antibodies to either vWF or CD31, increased significantly (P < 0.0001) with disease progression from normal oral mucosa, through mild, moderate, and severe dysplasia to early and late carcinoma (76 paraffin-embedded tissues examined). In contrast, h-MVD did not discriminate between dysplastic lesions and carcinoma. A similar percentage of the total vessel volume (MVV) and density (h-MVD) were positive for alpha v beta 3 in 24 frozen tissues examined, including normal oral mucosa. It is concluded that there is a close association between vascularity and tumour progression in the oral mucosa. Morphometric analysis reflecting microvascular volume is more informative than the currently popular analysis of microvascular density. The expression of alpha v beta 3 in the vasculature of oral tissues does not necessarily reflect the presence of angiogenic vessels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9370945     DOI: 10.1002/(SICI)1096-9896(199709)183:1<39::AID-PATH1088>3.0.CO;2-L

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  44 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  Evaluation of angiogenesis by morphometric analysis of blood vessels in dysplastic and neoplastic lesions of canine gingiva.

Authors:  M Martano; P Maiolino; M Cataldi; B Restucci
Journal:  Vet Res Commun       Date:  2004-08       Impact factor: 2.459

3.  CD151 gene delivery activates PI3K/Akt pathway and promotes neovascularization after myocardial infarction in rats.

Authors:  Zhenzhong Zheng; Zhengxiang Liu
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

4.  Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer.

Authors:  Ina Pavlova; Crystal Redden Weber; Richard A Schwarz; Michelle Williams; Adel El-Naggar; Ann Gillenwater; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2008 Nov-Dec       Impact factor: 3.170

5.  Angiogenesis and the growth potential of craniopharyngiomas.

Authors:  Sergio Vidal; Bernd W Scheithauer; Kalman Kovacs; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  Histomorphometric Analysis of Angiogenesis using CD31 Immunomarker and Mast Cell Density in Oral Premalignant and Malignant Lesions: A Pilot Study.

Authors:  M Jyothsna; M Rammanohar; Kiran Kumar
Journal:  J Clin Diagn Res       Date:  2017-01-01

7.  Angiogenesis in oral squamous cell carcinoma.

Authors:  G Ascani; P Balercia; M Messi; L Lupi; G Goteri; A Filosa; D Stramazzotti; T Pieramici; C Rubini
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

8.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

9.  A three-dimensional analysis of blood vessels in bronchioloalveolar carcinoma.

Authors:  Takeshi Uehara; Takayuki Honda; Kenji Sano; Tsutomu Hachiya; Hiroyoshi Ota
Journal:  Lung       Date:  2004       Impact factor: 2.584

10.  Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.

Authors:  Yurdanur Sullu; Seda Gun; Sinan Atmaca; Filiz Karagoz; Bedri Kandemir
Journal:  Diagn Pathol       Date:  2010-06-14       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.